GDRX News

The US IPO market has already posted its busiest year since the internet bubble in 2000, and we expect issuance to stay active in the fall. With broader equity markets at all-time highs and a burgeoning IPO pipeline of private unicorns, many long-awaited names will finally take the leap to public markets, supported by the busiest month of August for new filings in over a decade....read more

IPO Frenzy Drives Busiest Third Quarter Since 2000 The US IPO market had its busiest third quarter by deal count since the Dot-com era, with 81 IPOs raising $28.5 billion. The high volume combined with several large deals resulted in the largest quarter by proceeds in six years. IPOs performance remained strong,...read more

September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx (GDRX) priced well above the range to raise $1.1 billion at a $14.2 billion market cap. The company provides one of the...read more

GoodRx Holdings, which operates a prescription drug price comparison platform, raised $1.1 billion by offering 34.6 million shares (32% insider) at $33, above the range of $24 to $28. GoodRx Holdings plans to list on the Nasdaq under the symbol GDRX. Morgan Stanley, Goldman Sachs, J.P. Morgan, Barclays, BofA Securities, Citi, Credit Suisse, RBC Capital Markets, UBS Investment Bank...read more